{"id":5947,"date":"2024-05-29T14:15:18","date_gmt":"2024-05-29T12:15:18","guid":{"rendered":"https:\/\/www.ehc.eu\/uncategorized-hr\/zajednicka-izjava-podrske-eahad-eha-ehc-nacrtu-smjernica-ema-e-za-klinicke-zahtjeve-za-terapiju-bez-zamjene-kod-hemofilije-a-i-b\/"},"modified":"2026-04-02T16:30:33","modified_gmt":"2026-04-02T14:30:33","slug":"zajednicka-izjava-podrske-eahad-eha-ehc-nacrtu-smjernica-ema-e-za-klinicke-zahtjeve-za-terapiju-bez-zamjene-kod-hemofilije-a-i-b","status":"publish","type":"post","link":"https:\/\/www.ehc.eu\/hr\/uvidi\/zajednicka-izjava-podrske-eahad-eha-ehc-nacrtu-smjernica-ema-e-za-klinicke-zahtjeve-za-terapiju-bez-zamjene-kod-hemofilije-a-i-b\/","title":{"rendered":"Zajedni\u010dka izjava podr\u0161ke EAHAD-EHA-EHC nacrtu smjernica EMA-e za klini\u010dke zahtjeve za terapiju bez zamjene kod hemofilije A i B"},"content":{"rendered":"<!-- hero -->\t<section   class=\"subpage-hero bg-white\">\n\t\t<div class=\"container\">\n\t\t\t<div class=\"relative z-10\">\n\t\t\t\t<div class=\"pt-16 lg:pt-24 pb-24 lg:pb-32\">\n\t\t\t\t\t<div class=\"row justify-between gap-10 lg:gap-0 mt-10 text-center lg:text-left\">\n\t\t\t\t\t\t<div class=\"w-full lg:w-6\/12 lg:self-center\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"title h2\" data-scroll data-fade-up>\n\t\t\t\t\t\t\t\t\t<p class=\"text-[115%]\">Zajedni\u010dka izjava podr\u0161ke EAHAD-EHA-EHC nacrtu smjernica EMA-e za klini\u010dke zahtjeve za terapiju bez zamjene kod hemofilije A i B<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<figure class=\"absolute size-[41.8rem] lg:size-[82.8rem] bottom-[-10%] right-[-10rem] lg:right-[-5%] image-contain opacity-100 skip-lazy\" data-parallax>\n\t\t\t\t\t<img decoding=\"async\" loading=\"eager\" src=\"https:\/\/etngbd86n6b.exactdn.com\/wp-content\/themes\/cbd\/img\/content-logo-colorfull-2.svg\" alt=\"content-logo-colorfull\">\n\t\t\t\t<\/figure>\n\t\t\t\t\t\t<\/section>\n<!-- overview -->\t<section   class=\"s-overlay-img s-padding bg-red\">\n\t\t<div class=\"container\">\n\t\t\t<div class=\"row w-full lg:flex-row justify-between text-center lg:text-left gap-14 lg:gap-0 relative z-10\">\n\t\t\t\t\t\t\t\t<div class=\"w-full lg:py-10\">\n\t\t\t\t\t<div class=\"bg-white min-h-full py-12 px-10 lg:py-24 lg:pl-24 xl:pl-44 relative radius-20 z-10\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"content mt-8\" data-scroll data-fade-up>\n\t\t\t\t\t\t\t\t<p>Posljednjih trideset godina, pacijenti s hemofilijom A i B lije\u010deni su kori\u0161tenjem FVIII i FIX zamjenskih koncentrata. Te su terapije dobro poznate i klini\u010darima i pacijentima. Sada ulazimo u novu eru u lije\u010denju hemofilije i rijetkih poreme\u0107aja krvarenja. Nove, ne-zamjenske terapije su odobrene i postaju dostupne, \u0161to mo\u017ee zna\u010dajno utjecati na klini\u010dku skrb i kvalitetu \u017eivota pacijenata.   <\/p>\n<p><strong><a href=\"https:\/\/www.ema.europa.eu\/en\/homepage\" target=\"_blank\" rel=\"noopener\">Europska agencija za lijekove (EMA) pokrenula<\/a><\/strong> je u listopadu 2023. javnu konzultaciju o svom nacrtu smjernica o klini\u010dkim zahtjevima za terapiju bez zamjene kod hemofilije A i B. Kraj konzultacija i rok za komentare bio je 30. travnja 2024.<\/p>\n<p><strong><a href=\"https:\/\/www.eahad.org\/\" target=\"_blank\" rel=\"noopener\">Europsko udru\u017eenje za hemofiliju i srodne poreme\u0107aje (EAHAD),<\/a><\/strong> <strong>Europsko hematolo\u0161ko udru\u017eenje (EHA)<\/strong> i <strong>EHC<\/strong> podr\u017eavaju napore EMA-e u izradi smjernica koje imaju za cilj pru\u017eiti podnositeljima zahtjeva i regulatorima prijeko potrebne uskla\u0111ene zahtjeve za odobrenje za stavljanje u promet za primjene terapija koje nisu zamjenske za hemofiliju A i B.<\/p>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"bottom mt-12\" data-scroll data-fade-up>\n\t\t\t\t\t\t\t\t<a href=\"https:\/\/ehc.eu\/wp-content\/uploads\/2024\/10\/Joint-Support-Statement-on-EMA-guideline-for-haemophilia_EAHAD-EHA-EHC.pdf\" target=\"_blank\" class=\"btn with-icon\">\n\t\t\t\t\t\t\t\t\t<span>Read the full joint support statement <\/span>\n\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/section>\n","protected":false},"excerpt":{"rendered":"<p>EAHAD, EHA i EHC podr\u017eavaju napore EMA-e u izradi smjernice koja ima za cilj pru\u017eiti i podnositeljima zahtjeva i regulatorima prijeko potrebne uskla\u0111ene zahtjeve za odobrenje za stavljanje u promet za primjenu terapija koje nisu zamjenske za hemofiliju A i B.<\/p>\n","protected":false},"author":2,"featured_media":5949,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[125],"tags":[129],"class_list":["post-5947","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uvidi","tag-stajaliste"],"acf":[],"jetpack_featured_media_url":"https:\/\/etngbd86n6b.exactdn.com\/wp-content\/uploads\/2024\/11\/EAHAD-EHA-EHC-support-statement-Logo.png?strip=all&sharp=1","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.ehc.eu\/hr\/wp-json\/wp\/v2\/posts\/5947","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ehc.eu\/hr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ehc.eu\/hr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ehc.eu\/hr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ehc.eu\/hr\/wp-json\/wp\/v2\/comments?post=5947"}],"version-history":[{"count":1,"href":"https:\/\/www.ehc.eu\/hr\/wp-json\/wp\/v2\/posts\/5947\/revisions"}],"predecessor-version":[{"id":5950,"href":"https:\/\/www.ehc.eu\/hr\/wp-json\/wp\/v2\/posts\/5947\/revisions\/5950"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ehc.eu\/hr\/wp-json\/wp\/v2\/media\/5949"}],"wp:attachment":[{"href":"https:\/\/www.ehc.eu\/hr\/wp-json\/wp\/v2\/media?parent=5947"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ehc.eu\/hr\/wp-json\/wp\/v2\/categories?post=5947"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ehc.eu\/hr\/wp-json\/wp\/v2\/tags?post=5947"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}